SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 22, 2003
ORPHAN MEDICAL, INC.
--------------------
(Exact name of registrant as specified in its charter)
Delaware 0-24760 41-1784594
-------- ------- ----------
(State or other jurisdiction (Commission (I.R.S. employer
of incorporation) file number) identification number)
Suite 250,
13911 Ridgedale Drive,
Minnetonka, MN 55305 (952) 513-6900
-------------- ----- --------------
(Address of principal (zip code) (Registrant's telephone
executive offices) number, including area code)
Not Applicable
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 12. Disclosure of Results of Operations and Financial Condition.
On October 22, 2003, the Company issued a press release setting forth the
Company's results of operations and financial condition for the third fiscal
quarter of 2003 and year-to-date 2003. A copy of the Company's press release is
attached hereto as Exhibit 99.1 and is incorporated herein by reference.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 23, 2003 ORPHAN MEDICAL, INC.
/s/ Timothy G. McGrath
-------------------------------------
Timothy G. McGrath
Chief Financial Officer
(duly authorized officer and
principal financial officer)
EXHIBIT INDEX
Exhibit
Number Description
99.1 Press release dated October 22, 2003.